CELLULAR AND HUMORAL IMMUNE-RESPONSES TO ADENOVIRAL VECTORS CONTAINING FACTOR-IX GENE - TOLERIZATION OF FACTOR-IX AND VECTOR ANTIGENS ALLOWS FOR LONG-TERM EXPRESSION
被引:557
作者:
DAI, YF
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
DAI, YF
SCHWARZ, EM
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
SCHWARZ, EM
GU, DL
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
GU, DL
ZHANG, WW
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
ZHANG, WW
SARVETNICK, N
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
SARVETNICK, N
VERMA, IM
论文数: 0引用数: 0
h-index: 0
机构:SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
VERMA, IM
机构:
[1] SALK INST, MOLEC BIOL & VIROL LAB, SAN DIEGO, CA 92186 USA
[2] Scripps Res Inst, DEPT NEUROPHARMACOL CVN10, LA JOLLA, CA 92037 USA
[3] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT THORAC CANC & CARDIOVASC SURG, HOUSTON, TX 77030 USA
Recombinant adenoviruses containing the canine factor IX (FIX) cDNA were directly introduced in the hind leg muscle of mice, We show that (i) in nude mice, high expression (1-5 mu g/ml in plasma) of FIX protein can be detected for >300 days; (ii) in contrast, expression of FIX protein was transient (7-10 days) in normal mice; (iii) CD8(+) lymphocytes could be detected within 3 days in the infected muscle tissue; (iv) use of beta(2)-microglobulin and immunoglobulin M heavy chain ''knockout'' mice showed that lack of sustained expression of FIX protein is due to cell-mediated and humoral immune responses; (v) normal mice, once infected with recombinant adenovirus, could not be reinfected efficiently for at least 30 days due to neutralizing viral antibodies; and, finally, (vi) using immunosuppressive drugs, some normal mice can be tolerized to produce and secrete FIX protein for >5 months. We conclude that currently available adenoviral vectors have serious limitations for use for longterm gene therapy.